BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20486860)

  • 1. Systemic delivery of therapeutics to neuronal tissues: a barrier modulation approach.
    Campbell M; Ozaki E; Humphries P
    Expert Opin Drug Deliv; 2010 Jul; 7(7):859-69. PubMed ID: 20486860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Various drug delivery approaches to the central nervous system.
    Pasha S; Gupta K
    Expert Opin Drug Deliv; 2010 Jan; 7(1):113-35. PubMed ID: 20017662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrier modulation in drug delivery to the retina.
    Campbell M; Humphries MM; Humphries P
    Methods Mol Biol; 2013; 935():371-80. PubMed ID: 23150382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference therapy for glioblastoma.
    Guo D; Wang B; Han F; Lei T
    Expert Opin Biol Ther; 2010 Jun; 10(6):927-36. PubMed ID: 20415602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of RNA interference triggers to sensory neurons in vivo using herpes simplex virus.
    Anesti AM; Coffin RS
    Expert Opin Biol Ther; 2010 Jan; 10(1):89-103. PubMed ID: 20420517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical permeation enhancers for transbuccal drug delivery.
    Hassan N; Ahad A; Ali M; Ali J
    Expert Opin Drug Deliv; 2010 Jan; 7(1):97-112. PubMed ID: 20017661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery to the central nervous system: a review.
    Misra A; Ganesh S; Shahiwala A; Shah SP
    J Pharm Pharm Sci; 2003; 6(2):252-73. PubMed ID: 12935438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicated chewing gum--a potential drug delivery system.
    Chaudhary SA; Shahiwala AF
    Expert Opin Drug Deliv; 2010 Jul; 7(7):871-85. PubMed ID: 20560779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Trojan horses for blood-brain barrier drug delivery.
    Pardridge WM
    Discov Med; 2006 Aug; 6(34):139-43. PubMed ID: 17234133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the brain--surmounting or bypassing the blood-brain barrier.
    Potschka H
    Handb Exp Pharmacol; 2010; (197):411-31. PubMed ID: 20217538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
    Gabathuler R
    Neurobiol Dis; 2010 Jan; 37(1):48-57. PubMed ID: 19664710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible and size-selective opening of the inner Blood-Retina barrier: a novel therapeutic strategy.
    Campbell M; Nguyen AT; Kiang AS; Tam L; Kenna PF; Dhubhghaill SN; Humphries M; Farrar GJ; Humphries P
    Adv Exp Med Biol; 2010; 664():301-8. PubMed ID: 20238029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of EGFR in malignant gliomas.
    Ye F; Gao Q; Cai MJ
    Expert Opin Ther Targets; 2010 Mar; 14(3):303-16. PubMed ID: 20148717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference to target lipid disorders.
    Rondinone CM
    Curr Opin Lipidol; 2008 Jun; 19(3):285-8. PubMed ID: 18460920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug delivery to brain tumours: challenges and progress.
    Ningaraj NS
    Expert Opin Drug Deliv; 2006 Jul; 3(4):499-509. PubMed ID: 16822225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAi-mediated barrier modulation: synergies of the brain and eye.
    Hanrahan F; Humphries P; Campbell M
    Ther Deliv; 2010 Oct; 1(4):587-94. PubMed ID: 22833969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-viral nanovectors for gene delivery: factors that govern successful therapeutics.
    Viola JR; El-Andaloussi S; Oprea II; Smith CI
    Expert Opin Drug Deliv; 2010 Jun; 7(6):721-35. PubMed ID: 20367531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference and potential therapeutic applications of short interfering RNAs.
    Karagiannis TC; El-Osta A
    Cancer Gene Ther; 2005 Oct; 12(10):787-95. PubMed ID: 15891770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.